Therefore, OspC C7 may be a viable candidate for a human Lyme disease vaccine These studies indicate that including OspC in a comprehensive Lyme disease vaccine may be vital. Vaccination with OspC ...

the bacterium that causes Lyme disease. The vaccine blocks the protein, OspA, which prevents the spiral-shaped bacterium from being able to leave the tick and infect any humans it has bitten ...

Linden Hu, a professor of immunology specializing in Lyme disease at Tufts University, explains why creating a good Lyme vaccine is so ... A), but when it enters humans, OspA shuts off and the ...

With this success and seeing that mice and human immune cells react similarly ... several applications for their patented vaccine strategy against Lyme disease. This may include working with ...

While most tick bites are harmless, some can spread bacterial infections like Lyme disease. “We've known for years ... the safety of their engineered CspZ protein-based vaccine strategy by conducting ...

It’s in those days of quiet blood-thirst that ticks pass along bacteria that causes conditions like Lyme disease ... the tiny tick is able to evade the human body’s defenses and pass along ...

Lyme disease and tick-borne illnesses have also been on the rise nationally. The U.S. Centers for Disease Control and ...

Lyme disease and anaplasmosis, which both come from tick bites, are increasing significantly in Michigan over the past five years.